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Abstract: To design ARC-111 analogues with improved efficiency, we constructed the 
QSAR of 22 ARC-111 analogues with RPMI8402 tumor cells. First, the optimized support 
vector regression (SVR) model based on the literature descriptors and the worst descriptor 
elimination multi-roundly (WDEM) method had similar generalization as the artificial 
neural network (ANN) model for the test set. Secondly, seven and 11 more effective 
descriptors out of 2,923 features were selected by the high-dimensional descriptor selection 
nonlinearly (HDSN) and WDEM method, and the SVR models (SVR3 and SVR4) with 
these selected descriptors resulted in better evaluation measures and a more precise 
predictive power for the test set. The interpretability system of better SVR models was 
further established. Our analysis offers some useful parameters for designing ARC-111 
analogues with enhanced antitumor activity. 
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1. Introduction 
Topoisomerase I (TOP I) is a clinical target for the treatment of cancer [1]. Camptothecin (CPT) 
and several CPT derivatives (e.g., CPT-11, topotecan) have been developed for clinical use due to  
CPT-induced TOP I inhibition, referred to as a cleavage complex. Despite their potential, CPTs are 
chemically unstable, and are substrates for the ATP-binding cassette (ABC) transporter breast cancer 
resistance protein (BCRP) known to be expressed in many human tumors, which bind to human serum 
albumin (HAS) in their carboxylate forms, leading to reduced potency in humans compared to  
mice [2]. So it is necessary and important to develop alternative TOP I targeting agents.  
8,9-Dimethoxy-5-(2-N,N-dimethylaminoethyl)-2,3-methylenedioxy-5H-dibenzo[c,h][1,6] naphthyridin-6-
one (ARC-111) is a promising new TOP I-targeting antitumor drug with a different drug resistance 
profile [2]. Cytotoxicity of ARC-111 in RPMI 8402 tumor cells has been proved to be correlated with 
TOP I-targeting activity, so ARC-111 is thought to be one of the assessment indicators for antitumor 
activities [3]. 
The quantitative structure-activity relationship (QSAR) is a powerful approach used for studying 
the relationship between drug activities and molecular structures, and it is helpful to explain how 
structural features determine drug activities. Especially, an acceptable QSAR has the advantages of 
higher-speed and lower-costs than experimental testing for drug activity evaluation. Yu et al. have 
compared QSAR modeling of antitumor activity of ARC-111 analogues using stepwise multiple linear 
regression (stepwise MLR), partial least squares (PLS) and artificial neural network (ANN), and the 
results showed the ANN model was the most powerful for the test [4]. However, the ANN model still 
had an obvious defect in the reliability of structural information because its independent variables had 
to be selected by linear techniques from only 15 molecular descriptors, so the QSAR of an increasing 
number of ARC-111 analogues possessing antitumor activities are still not well understood. Therefore, 
selecting more effective molecular features from the high-dimensional ones of ARC-111 analogues 
using new methods will possibly provide more useful information for the design of new antitumor 
drugs. Parameter Client provides an interface for different programs that calculate several groups of 
descriptors with a total number of >3000 [5]. For each ARC-111 analogue, its high-dimensional 
descriptors could be calculated freely and quickly. Because many of these descriptors are redundant 
and sometimes irrelevant, models for nonlinear selection of the most useful subset of descriptors are 
needed for theoretical analysis and for practical applications.  
The support vector machine (SVM) is a class of learning-based nonlinear modeling technique with 
proven performance in a wide range of practical applications [6]. Originally, SVMs were developed 
for classification or qualitative modeling problems. With the introduction of a ε-insensitive loss 
function, SVM has been extended to solve nonlinear regression (or quantitative modeling) problems. 
To select reasonable features, we employed two in-house developed methods based on SVM 
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regression (SVR): the worst descriptor elimination multi-roundly (WDEM) [7] and the high-
dimensional descriptors selection nonlinearly (HDSN) [8], and then constructed QSAR models of 
ARC-111 analogues based on the SVR technique in this study. 
The objectives of this work were: (1) to test the effectiveness of the SVR model on ARC-111 
analogues by comparing them with other chemometric tools including stepwise MLR, PLS, and ANN; 
(2) to construct and evaluate QSAR models using SVR with selection of descriptors from  
high-dimensional features of ARC-111 analogues; (3) to analyze the explanatory power of the SVR 
models; and (4) to predict the activities of several theoretical drugs based on our model and thus 
provide specific parameters for future drug development. 
2. Results and Discussion 
2.1. Comparative QSAR Modeling with the Low-Dimensional Literature Descriptors Using Stepwise 
MLR, PLS, ANN and SVR Techniques 
To verify the generalization ability of QSAR constructed using SVR technique, a low-dimensional 
literature dataset with 9 descriptors was adopted. The 9 descriptors were the combined set of features 
from stepwise MLR and PLS in [4].To further eliminate the redundant descriptors from this literature 
dataset, every available descriptor were gradually removed one by one from the model using our 
WDEM method (10-fold cross-validation) until the model with the lowest MSE was obtained. Six key 
descriptors [MW, Dipole, MolPol, JGT, E(H-bond) and ∆ 0fH ] were reserved by 3 rounds of nonlinear 
selection. Then the two low-dimensional datasets with 9 and 6 descriptors, respectively, were trained 
by leave-one-out (LOO) cross-validation and modeled in five Kernel functions (t = 0;  
t = 1, d = 2; t = 1, d = 3; t = 2; t = 3). The results of the independent test showed (1) the SVR1 model  
(t = 1, d = 3) with all literature features had higher predictive ability than stepwise MLR and PLS; and 
(2) the SVR2 model (t = 2) with MSE of 0.061, R2 of 0.950 and 2predR  of 0.918 for the test set had 
comparable predictive ability with the ANN (the number of units in hidden layers was four and the 
number in the training set was ten [4]) model even though SVR2 used less descriptors (Table 1). It 
indicated the SVR model was also a powerful technique for a given set of low-dimensional descriptors. 
Table 1. Comparative quantitative structure-activity relationship (QSAR) modeling of the 
independent test, based on the literature dataset. 
 Stepwise MLR PLS ANN SVR1 SVR2 
Number of descriptors  5 7 9 9 6 
MSE 0.201 0.167 0.050 0.141 0.061 
R2 0.910 0.890 0.962 0.937 0.950 
R2 0.730 0.775 0.933 0.811 0.918 
The SVR model with 6 descriptors (SVR2) produced better results than the SVR model with all 9 
descriptors (SVR1). We noted that the 6 descriptors were obtained with the WDEM from the 9 
descriptors. This showed that the WDEM method might be effective to choose relevant descriptors for 
more accurate prediction of the activities of ARC-111 analogues. This property will be helpful for the 
modeling with high-dimensional features. Considering nonlinear function, predictive ability and 
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computing time, the Radial Basis Function (t = 2) and 10-fold cross-validation will be adopted in 
future feature selecting, and the Radial Basis Function (t = 2) and LOO cross-validation will be 
adopted in independent tests. 
2.2. QSAR Modeling with the High-Dimensional Descriptors Using SVR Technique 
To improve drug design of ARC-111 analogues, the analysis of high-dimensional descriptors may 
result in better prediction. Using the software, PCLIENT, 2,923 molecular descriptors were calculated. 
Then the high-dimensional dataset containing the independent variables (all 2,923 descriptors) and the 
dependent variables [pIC50 (expt.) values] was used for modeling. Because the high-dimensional 
descriptors had more redundant information, we focused on how to select nonlinearly less but more 
critical descriptors using SVR. We have developed two novel methods that could select important 
descriptors from thousands of them. By initial coarse screening using the HDSN method to filter out 
irrelevant features, the data set would switch from high-dimensional into low-dimensional. Then 
further careful screening using the WDEM method would turn the data set with low-dimensional 
features into one with only important descriptors. Throughout the process, the descriptors in modeling 
with higher MSE values were removed gradually and nonlinearly until the model with the lowest MSE 
value was obtained. Finally, the SVR models for the test set based on the obtained descriptors were 
developed and evaluated. 
In feature screening, the Radial Basis Function (t = 2) and 10-fold cross-validation were adopted. 
Based on our HDSN method, descriptors of 18 ARC-111 analogues in SVR3 (and SVR4) model were 
reduced from 2,923 to 9 (and 13) by 9 (and 8) rounds of nonlinear screening. Furthermore, based on 
our WDEM method, descriptors were further reduced to 7 (and 11) by 2 rounds of nonlinear screening 
(Table 2). In the independent test, five Kernel functions and LOO cross-validation were adopted. 
Finally, the effective SVR3 and SVR4 models were obtained only by the Radial Basis Function (t = 2). 
The results of the independent test (Table 2) showed the SVR3 (and SVR4) models had similar or 
better predictive power with MSE of 0.032 (and 0.028), R2 of 0.964 (and 0.971) and 2predR  of 0.957 
(and 0.962) for the test set than stepwise MLR, PLS and ANN techniques. By nonlinear screening 
using our HDSN and WDEM methods, the SVR model with the obtained features from  
high-dimensional features of ARC-111 analogues had stronger generalization ability than all reference 
models for antitumor activity prediction in RPMI 8402. Furthermore, based on the SVR4 model,  
pIC50 (pred.) values of 12 theoretical ARC-111 analogues were predicted for drug activity evaluation. 
The results showed no drug with higher antitumor activity appeared in these theoretical designs, and 
suggested utilizing other substituents or other positions to design more effective drugs. 
Table 2. Comparative QSAR modeling of the independent test based on the high-dimensional 
descriptors selection using support vector regression (SVR). 
 Stepwise MLR PLS ANN SVR3 SVR4 
Number of descriptors  5 7 9 7 11 
MSE  0.201 0.167 0.050 0.032 0.028 
2R  0.910 0.890 0.962 0.964 0.971 
2
predR  0.730 0.775 0.933 0.957 0.962 
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The SVR3 and SVR4 models predicted that the antitumor activity of ARC-111 analogues depends 
on 7 and 11 molecular factors, respectively. According to the interpretability analysis of the SVR 
model we have established [9], the significance of the regression model and the importance of single 
indicator was obtained based on SVR and F-test. The results showed the nonlinear regression of the 
SVR3 model (R2 = 0.947) was highly significant because its F value (21.017) was greater than F0.01(7, 10) 
value, and the nonlinear regression of the SVR4 model (R2 = 0.947) was significant because its  
F value (7.310) was greater than F0.05(11, 6) value. The five most important descriptors in SVR3 were 
c6A (highly significant), ATS1v (highly significant), nCIC (highly significant), MATS3e (highly 
significant) and nCrs (significant), and the only one most important descriptor in SVR4 was BELv2 
(significant) (Table 3).  
Table 3. The retained descriptors by the high-dimensional descriptor selection nonlinearly 
(HDSN) and worst descriptor elimination multi-roundly (WDEM) methods and their  
F-test values. 
Model Group name Descriptor name F-value 
SVR3 GSFRAG c6A: Number of fragments Cyc6[A] 26.555 **
 2D autocorrelations 
 
ATS1v: Broto-Moreau autocorrelation of a topological structure - lag 1 / weighted 
by atomic van der Waals volumes 25.175 **
 Constitutional descriptors nCIC: Number of rings 12.210 **
 
 
2D autocorrelations 
 
MATS3e: Moran autocorrelation - lag 3 / weighted by atomic Sanderson 
electronegativities 12.114 **
 Functional group counts nCrs: Number of ring secondary C(sp3) 5.898 * 
 Topological charge indices GGI5: Topological charge index of order 5 3.687 
 Geometrical descriptors QYYv: Qyy COMMA2 value / weighted by atomic van der Waals volumes 2.387 
SVR4 BCUT descriptors 
 
BELv2: Lowest eigenvalue n. 2 of Burden matrix / weighted by atomic van der 
Waals volumes 11.382 * 
 GSFRAG-L p3-2N: Number of fragments Path3 with label N on atom 2 3.771 
 Randic molecular profiles SP20: Shape profile no. 20 3.511 
 Eigenvalue-based indices SEigZ: Eigenvalue sum from Z weighted distance matrix (Barysz matrix) 2.456 
 Constitutional descriptors nN: Number of Nitrogen atoms 2.456 
 RDF descriptors 
 
RDF040v: Radial distribution function - 4.0 / weighted by atomic van der Waals 
volumes 2.435 
 Walk and path counts TWC: Total walk count 2.425 
 RDF descriptors RDF040p: Radial distribution function - 4.0 / weighted by atomic polarizabilities 2.398 
 Topological descriptors ZM1V: first Zagreb index by valence vertex degrees 2.084 
 RDF descriptors 
 
RDF040e: Radial distribution function - 4.0 / weighted by atomic Sanderson 
electronegativities 1.304 
 GETAWAY descriptors HATS0u: Leverage-weighted autocorrelation of lag 0 / unweighted 0.599 
* p < 0.05; ** p < 0.01; F0.05(1,10) = 4.96; F0.01(1,10) = 10.04; F0.05(1,6) = 5.99; F0.01(1,6) = 13.74;  
F0.05(7,10) = 3.14; F0.01(7,10) = 5.2; F0.05(11,6) = 4.03; F0.01(11,6) = 7.8. 
The F-test values of the independent variables showed that GSFRAG, 2D autocorrelations and 
constitutional descriptors, played important roles in describing anticancer activities. According to the 
analysis of single indicator importance, c6A, ATS1v, nCIC, MATS3e and nCrs in the SVR3 model and 
BELv2 in the SVR4 model appeared to be the most significant descriptors of ARC-111 analogues. 
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ATS1v [10], nCIC [11], MATS3e [12–16], nCrs [17–23] and BELv2 [10,24–26] have been previously 
reported in different literature models, respectively. To our knowledge, c6A has never been reported as 
a critical descriptor, so it is unclear what new information is added as an important descriptor. Previous 
works have shown the physical and biological significance of several significant descriptors founded 
in our analysis. nCIC, as one of the highly significant descriptors, appears to have an influence on 
binding. It is likely that the active site of a possible target possesses more than one binding site, 
therefore the number of rings could be important for fitting into a hydrophobic pocket [11]. MATS3e, 
as one of the highly significant descriptors, are weighted by atomic Sanderson electronegativities, and 
might partly influence the drug aqueous solubility [15]. BELv2, weighted by atomic van der Waals 
volumes of Burden matrix, contribute to decrease the affinity of the ligands [25]. 
For all descriptors, the analysis of single-factor effects showed that the antitumor activity was 
positively correlated with nCrs values but negatively correlated with a further 6 descriptor values in 
the SVR3 model, and antitumor activity was positively correlated with HATS0u values but was 
negatively correlated with the values of a further 10 descriptors in the SVR4 model (Figure 1).  
Figure 1. Single-factor effects of features in the SVR3 (A) and SVR4 (B) models. 
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Perhaps, starting from a descriptor pool and then revealing the physico-chemical properties of a 
limited number of selected descriptors, as seen in some papers, can lead to a compromise between both 
approaches. In most of the models for prediction, theoretical molecular descriptors were used. 
Experimental chromatographic descriptors could be useful but are tedious to determine and therefore 
less popular [10]. Therefore, our results can be helpful to explain how descriptors could determine the 
antitumor activities of ARC-111 analogues, and improve drug design for new drug development. In 
addition to anticancer bioactivity [27], the structure activity relationship analysis can be applied to 
toxicology [28–30], etc. Therefore, a good QSAR model has broad application prospects. 
3. Materials and Methods 
3.1. Structures and Activities 
According to the types and roles of ARC-111 substituents reported in literature [3], 12 theoretical 
ARC-111 analogues were designed and evaluated. The structures of these 12 theoretical analogues and 
22 experimental ones from [4] were divided into four types (Figure 2) and listed in Table 4. IC50 (µM), 
the concentration of compounds causing 50% cell growth inhibition against tumor cell lines [3], are 
converted to negative logarithms of IC50 (pIC50) [4]. The collected 22 experimental pIC50 [pIC50 (expt.)] 
values against RPMI8402 tumor cells ranged from 6.071 to 9.523. To obtain statistically robust QSAR 
models and compare with the results of MLR, PLS, and ANN in [4], the experimental data sets in 
Table 4 were partitioned into the training set with 18 compounds and the test set with 4 compounds  
as in [4]. 
Figure 2. Four types of ARC-111 analogues structures. 
I II III IV 
Table 4. Substituents and activities of 34 ARC-111 analogues. 
Experimental drugs  Theoretical drugs 
Compound Type Substituent pIC50 (expt.) Compound Type Substituent pIC50 
(pred.)
b R1 R2 R3 R4 R1 R2 R3 R4 
1 I Me Me   8.699 1 I Me Et   8.651 
2  Me Bn   7.276 2  Me t-Bu   8.172 
3  Et Bn   7.114 3  Et t-Bu   7.876 
4  i-Pr Bn   6.523  4  t-Bu t-Bu   7.388 
5  t-Bu Bn   6.071 5  t-Bu i-Pr   6.908 
6  Bn Bn   6.420 6 III   Bn  6.668 
7  Et Et   8.222  7    Et  7.208 
8  i-Pr i-Pr   8.097a 8    t-Bu  6.904 
9  H Me   9.523 9    i-Pr  6.617 
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Table 4. Cont. 
Experimental drugs  Theoretical drugs 
Compound Type Substituent pIC50 (expt.) Compound Type Substituent pIC50 
(pred.)
b R1 R2 R3 R4 R1 R2 R3 R4 
10  H Et   8.699a 10 IV    Et 6.248 
11  H i-Pr   8.523  11     t-Bu 6.102 
12  H t-Bu   8.699  12     i-Pr 6.100 
13  H Bn   7.796         
14  H H   8.398         
15  Me i-Pr   8.097a         
16  Et i-Pr   8.301         
17 II     8.523         
18 III   H   8.155         
19    Me  7.523         
20 IV    Bn 6.398a        
21     H 7.046         
22     Me 6.523        
a Four experimental compounds in the test set; b predicted values of 12 theoretical compounds by the SVR4 model. 
3.2. Calculation of Molecular Descriptors 
First, to understand the QSAR reliability of modeling ARC-111 analogue activities using SVR 
technique, 4 electronic [Dipole, E(H-bond), ∆ 0fH and ET], 2 spatial (MW, Rg) and 1 physicochemical 
(MolPol) descriptors as well as different topological parameters (JGT, Wiener) from the literature were 
adopted to construct QSAR models. The 9 descriptors were obtained by molecule energy optimization 
using MM2 ChemOffice 2005, and then were calculated by MODEL and ChemOffice 2005 [4]. 
Second, to develop a better QSAR model based on high-dimensional data sample using SVR 
technique, molecular structures were represented by about 3,000 molecular descriptors that encoded 
much more structural information. These descriptors were generated by the software PCLIENT 
(http://www.vcclab.org/lab/pclient/) and classified under 24 groups (Table 5) [5]. The calculation 
process of the descriptors involved the following steps: the structures of the compounds were drawn 
using JME Editor of Peter Ertl and saved as SMILES files, and then the SMILES files as a task were 
added to the software PCLIENT for calculating all of the descriptors in the default state. 
Table 5. Group and count of descriptors from the software PCLIENT. 
Group No. Group of descriptors Count Group No. Group of descriptors Count
1 Constitutional descriptors 48 13 RDF descriptors 150 
2 Topological descriptors 119 14 3D-MoRSE descriptors 160 
3 Walk and path counts 47 15 WHIM descriptors 99 
4 Connectivity indices 33 16 GETAWAY descriptors 197 
5 Information indices 47 17 Functional group counts 121 
6 2D autocorrelations 96 18 Atom-centered 
fragments 
120 
7 Edge adjacency indices 107 19 Charge descriptors 14 
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Table 5. Cont. 
Group No. Group of descriptors Count Group No. Group of descriptors Count
8 BCUT descriptors 64 20 Molecular properties 28 
9 Topological charge indices 21 21 ET-state Indices >300
10 Eigenvalue-based indices 44 22 ET-state Properties * 3 
11 Randic molecular profiles 41 23 GSFRAG Descriptor 307 
12 Geometrical descriptors 74 24 GSFRAG-L Descriptor 886 
    Total: >3000
* This group of descriptors did not exist in the default state. 
3.3. Model Development 
To reduce dimensionality and improve model robustness in QSAR analysis, high-dimensional 
features would be screened coarsely and nonlinearly into low-dimensional features with lower mean 
squared error (MSE) by our HDSN method [8], and then low-dimensional features would be further 
screened nonlinearly by our WDEM method [31]. 
3.4. Model Evaluation 
The selection of descriptors and the optimization of Kernel functions parameters were examined by 
10-fold or LOO validation with the minimum MSE; the predictive capacity of the models was assessed 
based on MSE, the squared multiple correlation coefficient (R2) and the squared predictive correlation 
coefficient ( 2predR ) values calculated by the following equations: 
2ˆ( )i iy yMSE
n
   (1) 
2 2
2
2 2
ˆ ˆ( ) ( )
ˆ ˆ( ) ( )
i i
i i
y y y y
R
y y y y
    

   (2) 
2
2
2
ˆ( )
1
( )
i i
pred
i training
y y
R
y y
  

  (3) 
Here iy , ˆiy , y , yˆ  and n , respectively, represented the experimental values, the predicted values, 
the mean values of the experimental values, the mean values of the predicted values and the number of 
compounds of the test set, and trainingy  was the mean activity value of the training set. Generally, an 
acceptable QSAR model was considered to have a higher predictive power only having the lower  
MSE [31], the higher R2 [8] and the higher 2predR  (at least >0.6) [32] for the test set. 
4. Conclusions 
In our QSAR analysis, the structural information of 34 ARC-111 analogues was described using 
2923 molecular descriptors obtained. Two groups of more important descriptors were obtained using 
two nonlinear descriptor selection methods, and then used to model the activities of these ARC-111 
analogues based on SVR. The two SVR models demonstrated consistently better performance than 
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reference models in terms of prediction accuracy for the test data. Our results offer new theoretical 
tools for drug design and development. 
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